Scienture Holdings, Inc. (SCNX) Stock Analysis

Company Overview

Scienture Holdings, Inc. (SCNX) carries a market capitalisation of $15.32M. It is classified in the Pharmaceutical Retailers industry, within the Healthcare sector. The company reports 4 employees.

SCNX last closed at $0.37 on September 4, 2026. That is $0.00 (+0.81%) against the previous close. Over the past 52 weeks the price has ranged from $0.24 to $2.60. The latest close sits 56.72% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $431.61K. Against the prior fiscal year total of $136.64K, that is a change of +215.87%. The same year closed with a net loss of $41.51M. Profit margin runs at 0%. That is 11.9 percentage points above the Pharmaceutical Retailers median of −11.95%. Earnings per share on a trailing basis come to −2.03.

Across the 4 fiscal years on file, revenue moves from $10.25M in 2022 to $431.61K in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 18.65 times revenue. On price-to-sales that is 55.5 times the Pharmaceutical Retailers median of 0.34. 6 Pharmaceutical Retailers companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is −59.85%. Across 10 years the annualized return works out at −37.49%. The reported beta is 3.98. Annualized volatility over the trailing 10 years is 227.97%.

Growth & Income

No dividend is on file for SCNX.

The strongest complete calendar year on file is 2019 at +266.67%; the weakest is 2025 at −91.57%. Of the 9 complete calendar years on file, 2 finished higher. So far in 2026 the price is −26.86%.